Literature DB >> 23535322

Synthesis and evaluation of 2,5-di(4-aryloylaryloxymethyl)-1,3,4-oxadiazoles as anti-cancer agents.

H D Gurupadaswamy1, V Girish, C V Kavitha, Sathees C Raghavan, Shaukath Ara Khanum.   

Abstract

A series of 2,5-di(4-aryloylaryloxymethyl)-1,3,4-oxadiazoles 9a-j were obtained via multistep synthesis from hydroxybenzophenones 4a-e. The cytotoxicity of compounds 9a-j was evaluated against human leukemia cell lines (K562 and CEM). The compounds exhibited moderate to good anti-cancer activity with compounds 9b and 9i having a chloro group exhibiting the best activity (IC50 = 10 μM). Compound 9i exhibited activity against both the cell lines and 9b only exhibited activity against CEM. Further, a lactate dehydrogenase (LDH) assay and DNA fragmentation studies of the compounds 9a-j were also performed.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23535322     DOI: 10.1016/j.ejmech.2013.02.040

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  3 in total

1.  Development of a novel thymidylate synthase (TS) inhibitor capable of up-regulating P53 expression and inhibiting angiogenesis in NSCLC.

Authors:  Xin-Yang Li; De-Pu Wang; Guo-Qing Lu; Kai-Li Liu; Ting-Jian Zhang; Shuai Li; Kamara Mohamed O; Wen-Han Xue; Xin-Hua Qian; Fan-Hao Meng
Journal:  J Adv Res       Date:  2020-07-25       Impact factor: 10.479

2.  The critical role of novel benzophenone analogs on tumor growth inhibition targeting angiogenesis and apoptosis.

Authors:  Yasser Hussein Eissa Mohammed; Shaukath Ara Khanum
Journal:  Medchemcomm       Date:  2018-02-15       Impact factor: 3.597

Review 3.  Groundbreaking Anticancer Activity of Highly Diversified Oxadiazole Scaffolds.

Authors:  Alessandra Benassi; Filippo Doria; Valentina Pirota
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.